Tempus AI, Inc. (tem)
TEM — Company Overview
Investors tracking TEM follow a Health Information Services name listed on NMS within Healthcare.
| Ticker | TEM |
| Sector | Healthcare |
| Industry | Health Information Services |
| Exchange | NMS |
| Market cap | $13.82B |
| Last price | $76.59 |
| Size category | Large Cap |
TEM — Business Description
The business profile of Tempus AI, Inc. (TEM) reflects its role in Health Information Services. Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel s…
Official website: https://www.tempus.com.
TEM — Investment Thesis
Tempus AI, Inc. (TEM) attracts investors weighing Health Information Services fundamentals against current market pricing.
- Revenue is expanding at roughly 21.6% year-over-year (public data).
- Equity market capitalization is approximately $13.82B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
TEM — Financial Health
TEM financial profile reflects operating efficiency and capital structure using available market fundamentals.
Negative profit margin (-17.8%) signals near-term profitability pressure. Negative free cash flow of $-93.49M may require careful capital allocation. Debt-to-equity of 324.58 warrants monitoring in a higher-rate environment.
| Forward P/E | -9432.27× |
| Price / Sales | 9.65× |
| Price / Book | 31.00× |
| Gross margin | 64.0% |
| Operating margin | -20.1% |
| Profit margin | -17.8% |
| Return on equity | -67.4% |
| Debt / Equity | 324.58 |
| Free cash flow | $-93.49M |
TEM — Growth Outlook
Growth outlook for Tempus AI, Inc. (TEM) depends on demand trends in Health Information Services and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 21.6% indicates strong top-line momentum.
- Price is 26.6% below the 52-week high.
TEM — Competitive Position
Tempus AI, Inc. (TEM) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Health Information Services.
- Market capitalization of $13.82B places TEM among large-cap peers.
- Gross margin near 64.0% may reflect pricing power or favorable mix.
TEM — Strengths
Strengths for Tempus AI, Inc. (TEM) inferred from public financial metrics:
- Revenue growth of 21.6% year-over-year.
- Gross margin of 64.0% supports competitive unit economics.
- Large Cap scale ($13.82B) may provide distribution and funding advantages.
TEM — Weaknesses
Weaknesses and pressure points for Tempus AI, Inc. (TEM) based on available data:
- Thin profit margin (-17.8%).
- Negative free cash flow ($-93.49M).
- Elevated debt-to-equity (324.58).
- High beta (3.72) amplifies market swings.
- Price 27% below the 52-week high — sustained negative sentiment.
TEM — Opportunities
- Sustained revenue growth (21.6%) could support multiple expansion if margins hold.
TEM — Risks
- Beta of 3.72 implies above-market volatility.
- Leverage (debt/equity 324.58) raises sensitivity to credit conditions.
- Thin margins leave less room for operational missteps.
TEM — Summary
Tempus AI, Inc. (TEM) is a large-cap Healthcare company focused on Health Information Services, listed on NMS. Last price $76.59 with market cap $13.82B. Revenue grew 21.6% year-over-year per public data. Notable strengths include revenue growth of 21.6% year-over-year. Key watch items include thin profit margin (-17.8%). Review free estimates and earnings pages for TEM; upgrade for institutional ownership and live headlines.
Start Free — open TEM in Vest Terminal
Access live data, filings, ownership, and analysis for Tempus AI, Inc..
Tempus AI, Inc. FAQ
What does Tempus AI, Inc. (TEM) do?
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of…
What is TEM's P/E ratio?
Tempus AI, Inc. has a trailing P/E of N/A× based on publicly available market data.
Does TEM pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is TEM in?
Tempus AI, Inc. is classified in Healthcare (Health Information Services) on NMS.
What is TEM's market capitalization?
Approximate market cap: $13.82B.
What are the main risks for TEM?
Key risks include above-average volatility (beta 3.72), among factors on this page.
What are the strengths of TEM?
Potential positives include revenue growth of 21.6% year-over-year, gross margin of 64.0% supports competitive unit economics.
Where can I get analyst estimates for TEM?
Public analyst price targets and consensus for Tempus AI, Inc. are on the free /stocks/tem/estimates page. Deeper estimate history and models are available in Vest Terminal.